{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:05:18Z","timestamp":1783926318777,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404509"],"award-info":[{"award-number":["82404509"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119031","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:22:24Z","timestamp":1780327344000},"page":"119031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and anti-AML activity of guanidyl stapled peptide targeting MLAA-34\/MST3 interaction"],"prefix":"10.1016","volume":"316","author":[{"given":"Jingru","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-7713","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119031_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib2","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.33477","article-title":"Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2026.119031_bib4","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood.V96.4.1512","article-title":"Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells","volume":"96","author":"Niitsu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2025.05.038","article-title":"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis","volume":"80","author":"Zhang","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.119031_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3324\/haematol.2011.051532","article-title":"Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value","volume":"97","author":"Pratcorona","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2026.119031_bib7","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or chemotherapy for relapsed or refractory FLT3-Mutated AML","volume":"381","author":"Perl","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119031_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood.2019002140","article-title":"Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia","volume":"135","author":"Roboz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib9","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S2352-3026(18)30182-0","article-title":"Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial","volume":"6","author":"Short","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ejmech.2026.119031_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119031_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/leu.2014.62","article-title":"Chimeric antigen receptors against CD33\/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo","volume":"28","author":"Pizzitola","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.119031_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/leu.2014.242","article-title":"Resistance prediction in AML: analysis of 4601 patients from MRC\/NCRI, HOVON\/SAKK, SWOG and MD Anderson Cancer Center","volume":"29","author":"Walter","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.119031_bib13","unstructured":"Immunotherapy of Hematologic Malignancy - Pubmed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/14633789\/(accessed February 1, 2026)."},{"key":"10.1016\/j.ejmech.2026.119031_bib14","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","article-title":"CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia","volume":"100","author":"Scheibenbogen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.leu.2403186","article-title":"Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity","volume":"18","author":"Mail\u00e4nder","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2026.119031_bib16","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1073\/pnas.0405884101","article-title":"Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression","volume":"101","author":"Oka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119031_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1182\/blood-2004-12-4787","article-title":"Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM\/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia","volume":"106","author":"Greiner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119031_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00262-008-0552-z","article-title":"Identification and functional characterization of the novel acute monocytic leukemia associated antigen MLAA-34","volume":"58","author":"Zhang","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ejmech.2026.119031_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00262-011-0969-7","article-title":"Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia","volume":"60","author":"Zhao","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ejmech.2026.119031_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.leukres.2004.09.013","article-title":"Serological identification of immunogenic antigens in acute monocytic leukemia","volume":"29","author":"Chen","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2026.119031_bib21","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.7150\/jca.46670","article-title":"MLAA-34 knockdown shows enhanced antitumor activity via JAK2\/STAT3 signaling pathway in acute monocytic leukemia","volume":"11","author":"Lei","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119031_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-022-05021-4","article-title":"Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia","volume":"102","author":"Thakral","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejmech.2026.119031_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13008-023-00090-x","article-title":"Molecular mechanisms involved in regulating protein activity and biological function of MST3","volume":"18","author":"Qiu","year":"2023","journal-title":"Cell Div."},{"key":"10.1016\/j.ejmech.2026.119031_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbrc.2012.12.113","article-title":"Structural insights into the activation of MST3 by MO25","volume":"431","author":"Mehellou","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119031_bib25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s11426-024-1950-1","article-title":"Recent advances in chemical protein synthesis: method developments and biological applications","volume":"67","author":"Dong","year":"2024","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2026.119031_bib26","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1021\/acs.chemrev.0c00532","article-title":"Stapled helical peptides bearing different anchoring residues","volume":"120","author":"Li","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.ejmech.2026.119031_bib27","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1021\/ja000563a","article-title":"An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides","author":"Schafmeister","year":"2000","journal-title":"J. Am. Chem. Soc. Volumn: 122"},{"key":"10.1016\/j.ejmech.2026.119031_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/jacsau.3c00795","article-title":"Development of a double-stapled peptide stabilizing both \u03b1-Helix and \u03b2-Sheet structures for degrading transcription factor AR-V7","volume":"4","author":"Ma","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.ejmech.2026.119031_bib29","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.7150\/thno.75444","article-title":"Design of stapled peptide-based PROTACs for MDM2\/MDMX atypical degradation and tumor suppression","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119031_bib30","author":"Wang"},{"key":"10.1016\/j.ejmech.2026.119031_bib31","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1039\/D3SC04279K","article-title":"Cyclobutane-bearing restricted anchoring residues enabled geometry-specific hydrocarbon peptide stapling","volume":"14","author":"Chen","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119031_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4527","article-title":"RosettaDDGPrediction for high-throughput mutational scans: from stability to binding","volume":"32","author":"Sora","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119031_bib33","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1021\/acs.jcim.4c01718","article-title":"StaPep: an open-source toolkit for structure prediction, feature extraction, and rational design of hydrocarbon-stapled peptides","volume":"64","author":"Wang","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119031_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115118","article-title":"Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein","volume":"249","author":"Calugi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119031_bib35","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s41467-025-57196-9","article-title":"Structure-based discovery of hydrocarbon-stapled paxillin peptides that block FAK scaffolding in cancer","volume":"16","author":"Reyes","year":"2025","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:12:13Z","timestamp":1783923133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0223523426004769"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119031","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-AML activity of guanidyl stapled peptide targeting MLAA-34\/MST3 interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119031"}}